Science Explorer Back to mapMap
Discussion
Company · Rome · Italy

Angelini Pharma (Italy)

angelinipharma.comROR OpenAlex
World rank, all time
#33,073
of 34,923
Rank in Italy
#720
of 743
Research works
274
▲ 3% vs 2018-21
Citations
4.1k
15.1 per fractional work
Top-10% rate
8.9%
all institutions 10.0%
vs its own fields
0.80×
1.00× is exactly expected
Open access
35%
world 40%
International
27%
world 18%
Angelini Pharma (Italy)

Which fields of science does Angelini Pharma (Italy) work in?

In 2022-now, 51% of research at Angelini Pharma (Italy) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (47%), Neuroscience (10%), Biochemistry, Genetics and Molecular Biology (9%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 24 fractional works · 51.3% of its workMedicine: 23 fractional works · 47.4% of its workPsychiatry and Mental health: 5 fractional works · 11.1% of its workSurgery: 3 fractional works · 6.6% of its workPharmacology: 3 fractional works · 5.7% of its workPhysiology: 2 fractional works · 3.7% of its workRheumatology: 1 fractional works · 2.9% of its workInfectious Diseases: 1 fractional works · 2.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.6% of its workRehabilitation: 1 fractional works · 1.5% of its workDermatology: 1 fractional works · 1.2% of its workPathology and Forensic Medicine: 0 fractional works · 0.9% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.8% of its workOncology: 0 fractional works · 0.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.6% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.5% of its workEpidemiology: 0 fractional works · 0.5% of its workEmergency Medicine: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.4% of its workOtorhinolaryngology: 0 fractional works · 0.2% of its workUrology: 0 fractional works · 0.2% of its workNeurology: 0 fractional works · 0.2% of its workHealth Professions: 1 fractional works · 1.5% of its workOccupational Therapy: 0 fractional works · 0.6% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workComplementary and Manual Therapy: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 1 fractional works · 1.1% of its workNutrition and Dietetics: 1 fractional works · 1.1% of its workDentistry: 0 fractional works · 0.8% of its workOral Surgery: 0 fractional works · 0.4% of its workPeriodontics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workLife Sciences: 12 fractional works · 25.2% of its workNeuroscience: 5 fractional works · 9.7% of its workCellular and Molecular Neuroscience: 1 fractional works · 3.1% of its workBiological Psychiatry: 1 fractional works · 2.1% of its workCognitive Neuroscience: 1 fractional works · 1.3% of its workNeurology: 0 fractional works · 1.1% of its workBehavioral Neuroscience: 0 fractional works · 0.7% of its workDevelopmental Neuroscience: 0 fractional works · 0.7% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.5% of its workSensory Systems: 0 fractional works · 0.2% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 8.6% of its workMolecular Biology: 3 fractional works · 5.9% of its workGenetics: 1 fractional works · 1.2% of its workCancer Research: 0 fractional works · 0.6% of its workCell Biology: 0 fractional works · 0.6% of its workBiotechnology: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 3.3% of its workPharmaceutical Science: 1 fractional works · 2.3% of its workPharmacology: 0 fractional works · 1.0% of its workImmunology and Microbiology: 1 fractional works · 1.8% of its workImmunology: 0 fractional works · 1.1% of its workVirology: 0 fractional works · 0.4% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 1.7% of its workPlant Science: 0 fractional works · 0.9% of its workFood Science: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 7 fractional works · 14.9% of its workPsychology: 3 fractional works · 5.5% of its workExperimental and Cognitive Psychology: 1 fractional works · 2.3% of its workClinical Psychology: 1 fractional works · 1.7% of its workSocial Psychology: 0 fractional works · 0.9% of its workApplied Psychology: 0 fractional works · 0.5% of its workSocial Sciences: 2 fractional works · 4.3% of its workSafety Research: 1 fractional works · 1.7% of its workEducation: 0 fractional works · 0.9% of its workSociology and Political Science: 0 fractional works · 0.8% of its workLaw: 0 fractional works · 0.4% of its workCultural Studies: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.7% of its workEconomics and Econometrics: 1 fractional works · 1.7% of its workDecision Sciences: 1 fractional works · 1.4% of its workInformation Systems and Management: 1 fractional works · 1.4% of its workArts and Humanities: 1 fractional works · 1.2% of its workReligious studies: 0 fractional works · 0.6% of its workPhilosophy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workBusiness, Management and Accounting: 0 fractional works · 0.8% of its workManagement Information Systems: 0 fractional works · 0.4% of its workAccounting: 0 fractional works · 0.3% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.2% of its workPhysical Sciences: 4 fractional works · 8.6% of its workEngineering: 1 fractional works · 2.7% of its workBiomedical Engineering: 1 fractional works · 1.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.7% of its workControl and Systems Engineering: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 1 fractional works · 2.2% of its workOrganic Chemistry: 1 fractional works · 1.6% of its workAnalytical Chemistry: 0 fractional works · 0.4% of its workInorganic Chemistry: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 1.6% of its workArtificial Intelligence: 1 fractional works · 1.4% of its workInformation Systems: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 1.5% of its workEnvironmental Chemistry: 0 fractional works · 0.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.4% of its workPollution: 0 fractional works · 0.4% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workALL ITS WORKAngelini Pharma(Italy)48fractional works, 2022-now
Life Sciences25%Physical Sciences9%Health Sciences51%Social Sciences15%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine2347.4%
    2. Health Professions11.5%
    3. Nursing11.1%
    4. Dentistry00.8%
    5. Veterinary00.4%
    1. Neuroscience59.7%
    2. Biochemistry, Genetics and Molecular Biology48.6%
    3. Pharmacology, Toxicology and Pharmaceutics23.3%
    4. Immunology and Microbiology11.8%
    5. Agricultural and Biological Sciences11.7%
    1. Psychology35.5%
    2. Social Sciences24.3%
    3. Economics, Econometrics and Finance11.7%
    4. Decision Sciences11.4%
    5. Arts and Humanities11.2%
    6. Business, Management and Accounting00.8%
    1. Engineering12.7%
    2. Chemistry12.2%
    3. Computer Science11.6%
    4. Environmental Science11.5%
    5. Mathematics00.4%
    6. Earth and Planetary Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.36× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.62× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.81× its world share, 1 worksImmunology and Micro…Neuroscience: 5.96× its world share, 5 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.45× its world share, 2 worksPharmacology, Toxico…Chemistry: 1.40× its world share, 1 worksChemistryComputer Science: 0.21× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.09× its world share, 0 worksEarth and Planetary …Engineering: 0.18× its world share, 1 worksEngineeringEnvironmental Science: 0.31× its world share, 1 worksEnvironmental ScienceMathematics: 0.30× its world share, 0 worksMathematicsDentistry: 1.69× its world share, 0 worksDentistryHealth Professions: 0.58× its world share, 1 worksHealth ProfessionsMedicine: 2.47× its world share, 22 worksMedicineNursing: 2.27× its world share, 0 worksNursingVeterinary: 3.01× its world share, 0 worksVeterinaryArts and Humanities: 0.43× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.26× its world share, 0 worksBusiness, Management…Decision Sciences: 1.45× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.78× its world share, 1 worksEconomics, Econometr…Psychology: 1.80× its world share, 3 worksPsychologySocial Sciences: 0.34× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.4×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics9.45×2 works
  2. Neuroscience5.96×5 works
  3. Veterinary3.01×0 works
  4. Medicine2.47×22 works
  5. Nursing2.27×0 works
  6. Immunology and Microbiology1.81×1 works
  7. Psychology1.80×3 works
  8. Dentistry1.69×0 works
  9. Biochemistry, Genetics and Molecular Biology1.62×4 works
  10. Decision Sciences1.45×1 works
  11. Chemistry1.40×1 works
  12. Economics, Econometrics and Finance0.78×1 works
  13. Health Professions0.58×1 works
  14. Arts and Humanities0.43×1 works
  15. Agricultural and Biological Sciences0.36×1 works
  16. Social Sciences0.34×2 works
  17. Environmental Science0.31×1 works
  18. Mathematics0.30×0 works
  19. Business, Management and Accounting0.26×0 works
  20. Computer Science0.21×1 works
  21. Engineering0.18×1 works
  22. Earth and Planetary Sciences0.09×0 works

Who are the top researchers at Angelini Pharma (Italy)?

Ranked on the quality score, Lavinia Silvestri, Angelo Guglielmotti and Francesco Paolo Di Giorgio lead among researchers whose main affiliation is Angelini Pharma (Italy).

  1. 1 Lavinia Silvestri Italy · #784,947 worldwide 383 citations · 23 works
  2. 2 Angelo Guglielmotti Italy · #2,203,979 worldwide 3.1k citations · 80 works
  3. 3 Francesco Paolo Di Giorgio Italy · #2,280,896 worldwide 3.1k citations · 41 works
  4. 4 Sara Zucchi Italy · #2,291,162 worldwide 1.1k citations · 34 works
  5. 5 Patrizio Scorza Barcellona Italy · #3,313,958 worldwide 915 citations · 36 works
  6. 6 Cesare De Martino Italy · #3,447,633 worldwide 4.2k citations · 106 works
  7. 7 Elena Álvarez‐Barón Italy · #3,879,616 worldwide 504 citations · 27 works
  8. 8 Alessandro Comandini Italy · #4,069,136 worldwide 963 citations · 57 works
  9. 9 Fabrizio Calisti Italy · #4,100,193 worldwide 302 citations · 25 works
  10. 10 V. M. Cioli Italy · #4,215,979 worldwide 613 citations · 26 works
All ranked researchers at Angelini Pharma (Italy)

What are the most cited papers from Angelini Pharma (Italy)?

The most cited paper from Angelini Pharma (Italy) is "Targeting Tumor-Associated Macrophages and Inhibition of MCP-1 Reduce Angiogenesis and Tumor Growth in a Human Melanoma Xenograft" (Silvina Gazzaniga, Alicia Bravo, Angelo Guglielmotti et al., 2007), with 302 citations. Next come "Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins" (299) and "The human microglial HMC3 cell line: where do we stand? A systematic literature review" (279).

Most cited papers
#PaperReleasedCitations
1 Targeting Tumor-Associated Macrophages and Inhibition of MCP-1 Reduce Angiogenesis and Tumor Growth in a Human Melanoma Xenograft Silvina Gazzaniga, Alicia Bravo, Angelo Guglielmotti et al. · Journal of Investigative Dermatology Open access 26 Apr 2007 302
2 Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins Maria Rosaria Romano, Luisa Diomede, Marina Sironi et al. · Laboratory Investigation Open access Jul 2000 299
3 The human microglial HMC3 cell line: where do we stand? A systematic literature review Cinzia Dello Russo, Natalia Cappoli, Isabella Coletta et al. · Journal of Neuroinflammation ReviewOpen access 10 Sep 2018 279
4 Rediscovering Trazodone for the Treatment of Major Depressive Disorder Andrea M. Fagiolini, Alessandro Comandini, Mario Catena Dell’Osso et al. · CNS Drugs Open access 13 Oct 2012 232
5 Morphological, histochemical and biochemical studies on germ cell mitochondria of normal rats Cesare De Martino, Aristide Floridi, Maria Luisa Marcante et al. · Cell and Tissue Research 1979 167
All 59 most cited papers, with filters and sorting

Which keywords describe research at Angelini Pharma (Italy)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Depression, Inflammation, Neurobiology, Synaptic Plasticity, Genetics, Epidemiology, Clinical Guidelines and Cognitive Impairment.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Depression5▲ 12×10 topics
  2. Inflammation5▲ 4.9×14 topics
  3. Epidemiology4▲ 2.4×19 topics
  4. Neurobiology3▲ 27×6 topics
  5. Synaptic Plasticity3▲ 31×2 topics
  6. Genetics3▲ 8.4×4 topics
  7. Oxidative Stress3▲ 3.6×11 topics
  8. Clinical Guidelines2▲ 17×2 topics
  9. Cognitive Impairment2▲ 19×2 topics
  10. Treatment-Resistant Depression2▲ 73×2 topics
  11. Antidepressant2▲ 187×1 topic
  12. Antiepileptic Drugs2▲ 61×2 topics
  13. Ketamine2▲ 187×1 topic
  14. Metabolic Syndrome2▲ 5.7×3 topics
  15. Neuroinflammation2▲ 16×4 topics
  16. Antipsychotic Drugs2▲ 98×1 topic
  17. Neurocognitive Deficits2▲ 98×1 topic
  18. Epilepsy2▲ 32×3 topics
  19. Meta-Analysis2▲ 5.9×3 topics
  20. Drug Resistance2▲ 12×2 topics
  21. Classification2▲ 6.7×1 topic
  22. Cognitive Function2▲ 17×2 topics
  23. Dendritic Spines2▲ 41×2 topics
  24. Prevalence2▲ 7.6×3 topics
  25. Seizures2▲ 50×1 topic
  26. Complications1▲ 5.3×2 topics
  27. Cytokines1▲ 9.7×2 topics
  28. Microglia1▲ 25×2 topics
  29. Anxiety1▲ 5.3×6 topics
  30. Brain Development1▲ 15×3 topics
  31. Matrix Metalloproteinases1▲ 17×3 topics
  32. Regeneration1▲ 12×2 topics
  33. Schizophrenia1▲ 21×2 topics
  34. Emotion Regulation1▲ 6.7×3 topics
  35. Health-related Quality of Life1▲ 8.9×2 topics
  36. Healthcare-Associated Infections1▲ 17×3 topics
  37. Immune Activation1▲ 26×1 topic
  38. Osteoarthritis1▲ 16×2 topics
  39. Patient Satisfaction1▲ 6.8×3 topics
  40. Tryptophan Metabolism1▲ 38×1 topic

Which research topics does Angelini Pharma (Italy) publish most on?

By volume in 2022-now: Treatment of Major Depression, Schizophrenia research and treatment, Epilepsy research and treatment and Tryptophan and brain disorders.

Treatment of Major Depression: 2 fractional worksSchizophrenia research and treatment: 2 fractional worksEpilepsy research and tr…2Epilepsy research and treatment: 2 fractional worksTryptophan and brain dis…1Tryptophan and brain disorders: 1 fractional worksOsteoarthritis Treatment and Mechanisms: 1 fractional worksNeuroscience and Neuropharmacology Research: 1 fractional worksTotal Knee Arthroplasty …1Total Knee Arthroplasty Outcomes: 1 fractional worksPain Mechanisms and Treatments: 1 fractional worksPharmacological Effects and Toxicity Studies: 1 fractional worksScientific Computing and Data Management: 1 fractional works
PharmacologyPsychiatry and Mental healthBiological PsychiatryRheumatology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Treatment of Major Depression Pharmacology 2 works
  2. 2 Schizophrenia research and treatment Psychiatry and Mental health 2 works
  3. 3 Epilepsy research and treatment Psychiatry and Mental health 2 works
  4. 4 Tryptophan and brain disorders Biological Psychiatry 1 works
  5. 5 Osteoarthritis Treatment and Mechanisms Rheumatology 1 works
  6. 6 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
  7. 7 Total Knee Arthroplasty Outcomes Surgery 1 works
  8. 8 Pain Mechanisms and Treatments Physiology 1 works
  9. 9 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 1 works
  10. 10 Scientific Computing and Data Management Information Systems and Management 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.0%not open65.0%

World: 40% of research is openly available.

with international co-authors27.0%domestic only73.0%

World: 18% is written across borders.

How has Angelini Pharma (Italy)'s research output changed?

Output in 2022-2025 was 3% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Angelini Pharma (Italy) as a percentage of every work published that year, 0.00023% in 2024.

still counting0.0010%0.0020%0.0030%Angelini Pharma (Italy)0.00013% in 202519801990200020102020

Fractional works of Angelini Pharma (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rome

All research institutions in Rome

Share Angelini Pharma (Italy)'s ranking

Angelini Pharma (Italy) on Science Explorer

A card with Angelini Pharma (Italy)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Angelini Pharma (Italy). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.